Please login to the form below

Not currently logged in
Email:
Password:

Lundbeck CEO resigns after rule breach

Lundbeck Ulf Wiinberg

Ulf Wiinberg accepted gift of shares in Stratified Medical

Orphan drugs in latest CHMP recommendations

EU flagEMA advisers back new products from Genzyme, Boehringer and others

Novartis gets EU nod for rare disease drug Signifor

Novartis buildingLong-acting formulation of drug approved for growth disorder acromegaly

EMA recommends two AbbVie treatments for hepatitis C

Exviera and Viekirax approved for use in Europe

AZ's new COPD therapy gets green light in Europe

AstraZeneca AZ headquarters London UKEC backs Duaklir in chronic respiratory condition

France agrees lowest Sovaldi pricing in EU

gilead-sciences-sovaldiGovernment brings cost of hepatitis C drug to €5,000 below list price

Purdue gets FDA nod for abuse-deterrent painkiller

Purdue HysinglaAround 105 people per day die from a drug overdose in the US

Stratified medicines face uptake challenges in the NHS

But 90% of HCPs believe the area will have a positive impact on the health system

UK to review life sciences environment

UK flagIntends to speed up access to medicines and medical technologies

Human cutout pyramidThe behavioural science of adherence

A broad range of factors can influence a person’s decision not to take treatment as prescribed but these can now be seen to be underpinned by academic principles

Latest appointments

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Medical Communications

dna: as different as you. Every patient, disease and therapy is di­fferent. As is every message, stakeholder and educational challenge....

Latest intelligence

More of the same: The importance of strategic communications planning for biosimilar entry
GCI Health's Hannah Morris considers the importance of strategic communications planning for biosimilar entry, a market anticipated to deliver between €8-26bn in savings across the European Union by 2020....
Online Physician Communities
How can pharma realise the power of digital?
Firstly, by making it owned and driven by the most senior leadership team in the business...
Remapping the market: Does Pharma's global model need a shake up?
For patients, carers and professionals, wherever they are in the world, digital technology is inherent in their everyday lives. Digital is, so to speak, a global language. The success of...